Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
Nampt inhibition with (E)-Daporinad (FK866) induces significant NAD+ intracellular reduction and selectively kills MM cells
Allosteric inhibitors of Bcr-abl-dependent cell proliferation
The ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with HCV replication and can be used to treat patients with genotypes 1a or 1b without PEG-interferon or ribavirin
(2010) Cell Stem Cell 7
8]indolizino[2
Obeticholic Acid - CAS# 459789-99-2 Catalog No.:M6685-2 Nampt inhibition with (E)-Daporinad (FK866)Obeticholic Acid, CAS No. 459789 99 2, is a novel derivative of cholic acid which acts as a potent and selective FXR agonist displaying anticholeretic activity in an in vivo rat model of cholestasis. It inhibits vascular smooth muscle cell inflammation and migration as well as promotes adipocyte differentiation and regulates adipose cell function in vivo. Product information CAS Number: 459789 99 2 Molecular Weight: 420. 63 Formula: C26H44O4 Synonym:
US$ 130.00
US$ 126.00
US$ 124.50
US$ 27.00
US$ 25.00
US$ 165.00
US$ 10.00
US$ 25.00